Cargando…
The role of human C5a as a non-genomic target in corticosteroid therapy for management of severe COVID19
Complement system plays a dual role; physiological as well as pathophysiological. While physiological role protects the host, pathophysiological role can substantially harm the host, by triggering several hyper-inflammatory pathways, referred as “hypercytokinaemia”. Emerging clinical evidence sugges...
Autores principales: | Das, Aurosikha, Rana, Soumendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020607/ https://www.ncbi.nlm.nih.gov/pubmed/33845430 http://dx.doi.org/10.1016/j.compbiolchem.2021.107482 |
Ejemplares similares
-
Interaction of Human C5a with the Major Peptide Fragments
of C5aR1: Direct Evidence in Support of “Two-Site” Binding
Paradigm
por: Das, Aurosikha, et al.
Publicado: (2021) -
The Model Structures of the Complement Component 5a Receptor (C5aR) Bound to the Native and Engineered (h)C5a
por: Sahoo, Amita Rani, et al.
Publicado: (2018) -
Model structures of inactive and peptide agonist bound C5aR: Insights into agonist binding, selectivity and activation
por: Rana, Soumendra, et al.
Publicado: (2015) -
Role of human recombinant activated protein C and low dose corticosteroid therapy in sepsis
por: Shukla, Aparna, et al.
Publicado: (2010) -
Corticosteroids for Non-severe COVID-19: Primum Non Nocere
por: Muthu, Valliappan, et al.
Publicado: (2022)